Skip to content

Guttate, erythrodermic, or pustular psoriasis as sole or predominant form of psoriasis

Key exclusion criteria included guttate, erythrodermic or pustular psoriasis as the sole or predominant form of psoriasis. Patients were also ineligible if they had active disease rebound during or following discontinuation of previous efalizumab treatment (i. Key exclusion criteria included guttate, erythrodermic or pustular psoriasis as the sole or predominant form of psoriasis; withdrawal from previous efalizumab treatment as a result of lack of efficacy or an adverse event; history of opportunistic infections or ongoing uncontrolled infections or active tuberculosis (TB), or treatment for TB within 1 year prior to entry. Pustular psoriasis can also accompany other forms of psoriasis and can be very severe.

Guttate, erythrodermic, or pustular psoriasis as sole or predominant form of psoriasis 2Guttate, erythrodermic, or pustular psoriasis as sole or predominant form of psoriasis. Guttate, erythrodermic, or pustular psoriasis as sole or predominant form of psoriasis. PHOTOSENSITIVITY: Hypersensitivity to sunlight or UVB light of any type; history of Lupus, PMLE, or any disease known to be worsened by UV light exposure. Etanercept treatment should be discontinued in patients whose psoriasis has not responded adequately at 12 weeks. It is licensed for the ‘treatment of adults with moderate to severe plaque psoriasis who have failed to respond to, or who have a contraindication to, or who are intolerant to other systemic therapies including ciclosporin, methotrexate and PUVA’the UK marketing authorisation for efalizumab also specifies that the psoriasis should be chronic, and it is contraindicated in patients with specific forms of psoriasis like guttate, erythrodermic or pustular psoriasis as the sole or predominant form.

More specifically, the clinical spectrum of psoriasis includes the plaque, guttate, small plaque, inverse, erythrodermic, and pustular variants. The determinants of the clinical severity of psoriasis, the risk of comorbidities, and the quality of life of a psoriatic patient are influenced by multiple factors. 17, 18). The presence of psoriasis with sole scalp involvement may be difficult to discern. Inclusion Criteria: – Signed informed consent – Diagnosis of plaque psoriasis for 6 months – A minimum Psoriasis Area and Severity Index (PASI) score of 12. Guttate, erythrodermic, or pustular psoriasis as sole or predominant form of psoriasis – Clinically significant psoriasis flare during the 3 months prior to enrollment – Pregnancy or lactation – History of or ongoing uncontrolled bacterial, viral, fungal, or atypical mycobacterial infection – History of opportunistic infections (e. History of chronic plaque psoriasis vulgaris, for at least six months. Guttate, erythrodermic, or pustular psoriasis as sole or predominant form of psoriasis.

Payperview: Clinical Spectrum And Severity Of Psoriasis

Have guttate, erythrodermic or pustular psoriasis as the sole or predominant form of psoriasis.2. History of allergic or anaphylactic reactions to Cpn10.3. Have a clinically significant psoriasis flare during screening or at the time of enrolment. English. Patients with specific forms of psoriasis like guttate, erythrodermic or pustular psoriasis as sole or predominant form of psoriasis. The UK marketing authorisation for efalizumab also specifies that the psoriasis should be chronic, and it is contraindicated in patients with specific forms of psoriasis like guttate, erythrodermic or pustular psoriasis as the sole or predominant form.

Payperview: Clinical Spectrum And Severity Of Psoriasis